Study directory

Schizophrenia studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
4306studies shown
Showing 1,885-1,896 of 4,306
Drug study icon
TerminatedNCT02088060

Cannabidiol for Schizophrenia

This study was terminated in Denmark and in Germany. It is testing cannabidiol for Schizophrenia.

Multiple locations, including Glostrup Municipality
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 65 Years
Countries
Denmark, Germany
Sponsor
Central Institute of Mental Health, Mannheim
Condition
Schizophrenia
Drug study icon
CompletedNCT01626456

A Long-term Safety Study of ALKS 9072 (Also Known as ALKS 9070)

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Little Rock
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 70 Years
Countries
United States, Bulgaria, Malaysia, ...
Sponsor
Alkermes, Inc.
Condition
Schizophrenia
Drug study icon
TerminatedNCT01487083

A Long-Term Safety Study of Pomaglumetad Methionil in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Cerritos
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States, France, Austria, ...
Sponsor
Denovo Biopharma LLC
Condition
Schizophrenia
Drug study icon
CompletedNCT01561898

A Long-Term Study of JNS007ER in people with Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

Location not clearly listed
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugOver 20 Years
Countries
Sponsor
Janssen Pharmaceutical K.K.
Condition
Schizophrenia
Drug study icon
CompletedNCT01456897

A Long-term study of OPC-34712 in people with Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Kanto Region
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugOver 18 Years
Countries
Japan
Sponsor
Otsuka Pharmaceutical Co., Ltd.
Condition
Schizophrenia
Drug study icon
TerminatedNCT01129674

A Long-Term, Study on Schizophrenia

This study was terminated in the United States, in Croatia, in Japan, .... It focuses on schizophrenia.

Multiple locations, including Little Rock
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States, Croatia, Japan, ...
Sponsor
Denovo Biopharma LLC
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.